β³ Fetching live dividend data...
Home βΊ Calculator βΊ GOVXW Dividend Calculator 2026
GeoVax Labs, Inc. Β· NASDAQ
Price: $0.00 Β· Annual div: $2.00/share Β· Frequency: quarterly Β· Payout ratio: 50% Β· Ex-div: TBD
Click to apply scenario to the calculator
Year your monthly dividend income covers each expense (based on current settings)
$10,000 in GOVXW β $1.3083633484104228e+39M in 10 years Β· $109,030,092,703,477,080,000,000,000,000,000,000,000,000,000.00/month
GeoVax Labs, Inc. is a clinical-stage biotechnology firm dedicated to creating human vaccines and immunotherapies. The company's core mission involves tackling a range of infectious diseases and various solid tumor cancers. Their innovative approach is centered on a proprietary modified vaccinia ankara virus-like particle (MVA-VLP) vaccine platform. The company's pipeline includes diverse preventive vaccine candidates aimed at combating critical pathogens such as COVID-19, human immunodeficiency virus (HIV), Zika virus, malaria, and hemorrhagic fever viruses like Ebola, Sudan, Marburg, and Lassa. In parallel, GeoVax is advancing therapeutic vaccines designed to address existing conditions, including HIV, chronic Hepatitis B infections, and solid tumor malignancies. Key programs include GEO-CM04S1, a COVID-19 preventive vaccine candidate currently in Phase 2 clinical trials, and Gedeptin, a novel, patented product in Phase 1/2 clinical trials for treating advanced head and neck squamous cell carcinoma, which is also being explored for broader solid tumor applications. Additionally, the company is developing GEO-CM02, a pan-coronavirus vaccine. The preclinical stage features several other promising candidates, such as GEO-ZM02 for Zika, GEO-MM02 for malaria, GEO-EM01 for fever viruses (Ebola, Sudan, and Marburg), and GEO-LM01 targeting Lassa fever. GeoVax maintains strategic collaborations and partnership agreements with prominent institutions, including the National Institute of Allergy and Infectious Diseases (NIAID) within the National Institutes of Health, the U.S. Department of Defense, Emory University, and the Burnet Institute. Established in 1988, GeoVax Labs, Inc. operates from its headquarters in Smyrna, Georgia.
This calculation uses the DividendFlow Engine v6.0. Data is verified daily against SEC filings and FMP real-time feeds to ensure projection accuracy.
We'll send you a full breakdown of your projections, DRIP tips, and how to enable dividend reinvestment with your broker.
Free forever. No spam. Unsubscribe anytime. Β· Privacy Policy
Ready to invest? Open GOVXW position with:
Real after-tax yield depends on where you live and how you hold GOVXW.
| Account/Country | Tax Rate | After-tax Yield | Real Yield | $10K Annual Income |
|---|---|---|---|---|
| πΊπΈ Roth IRA / 401k | 0% | 57142.86% | 57140.06% | $5,714,286 / yr |
| πΊπΈ US Taxable (15%) β | 15% | 48571.43% | 48568.63% | $4,857,143 / yr |
| πΊπΈ US Taxable (20%) | 20% | 45714.29% | 45711.49% | $4,571,429 / yr |
| π¬π§ UK ISA | 0% | 57142.86% | 57140.06% | $5,714,286 / yr |
| π¬π§ UK Taxable | 8.75% | 52142.86% | 52140.06% | $5,214,286 / yr |
| π¨π¦ TFSA | 0% | 57142.86% | 57140.06% | $5,714,286 / yr |
| π¨π¦ CA Taxable | 25% | 42857.15% | 42854.35% | $4,285,715 / yr |
| π¦πΊ Super (pension) | 15% | 48571.43% | 48568.63% | $4,857,143 / yr |
| π¦πΊ AU Taxable | 30% | 40000.00% | 39997.20% | $4,000,000 / yr |
| π©πͺ DE Taxable | 26.375% | 42071.43% | 42068.63% | $4,207,143 / yr |
| π«π· FR Taxable | 30% | 40000.00% | 39997.20% | $4,000,000 / yr |
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
12-month CPI (US BLS via FMP economic-indicators).
Based on current dividend of $2.00/share/yr Β· πΊπΈ US Taxable (15%) Β· static projection (no growth assumed).
GOVXW pays quarterly β 4 times per year. Next ex-div: TBD.
How GOVXW compares to typical Healthcare averages.
Benchmarks: S&P 500 sector averages (2024β2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for GOVXW sourced from FMP /financial-growth endpoint β real data, not estimates.
When executives buy their own stock, it's a signal they believe in the dividend's sustainability.
| Insider | Title | Type | Date | Shares | Price | Total Value |
|---|---|---|---|---|---|---|
| A-Award | 2026-06-17 | 6,000 | $1.18 | $7.1K | ||
| A-Award | 2026-06-17 | 6,000 | $1.18 | $7.1K | ||
| A-Award | 2026-06-17 | 6,000 | $1.18 | $7.1K | ||
| A-Award | 2026-06-17 | 6,000 | $1.18 | $7.1K | ||
| A-Award | 2026-06-17 | 6,000 | $1.18 | $7.1K | ||
| A-Award | 2026-06-17 | 6,000 | $1.18 | $7.1K | ||
| A-Award | 2026-06-17 | 17,600 | $1.18 | $20.8K | ||
| A-Award | 2026-06-17 | 17,600 | $1.18 | $20.8K | ||
| A-Award | 2026-06-17 | 17,600 | $1.18 | $20.8K | ||
| A-Award | 2026-06-17 | 17,600 | $1.18 | $20.8K |
Insider transactions sourced from SEC Form 4 filings via Financial Modeling Prep. See disclaimer.
Altman Z-Score predicts bankruptcy risk. Piotroski F-Score measures financial strength across 9 criteria. High scores β lower dividend cut risk. Data via FMP financial statements.
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the GOVXW dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer β
GeoVax Labs, Inc. (GOVXW) is currently trading at $0.00, trading near its 52-week low. The current dividend yield is 57142.86% based on an annual payout of $2.00 per share.
GeoVax Labs, Inc. (GOVXW) is a healthcare stock currently trading at $0.00 with a dividend yield of 57142.86%. The company pays an annual dividend of $2.00 per share. The payout ratio of 50% suggests the dividend is well-covered by earnings.
Auto-generated from live market data. For educational purposes only β not financial advice.
Real users. No sign-up required to leave a review.
βFinally a free dividend calculator that doesn't make me sign up or connect my brokerage. Entered SCHD and got the full DRIP projection in seconds. Bookmarked immediately.β
βI've been trying to figure out how much dividend income I'd need to retire. This tool showed me exactly β $400K in JEPI at 7% yield gives me $2,333/month. No calculator did that this clearly before.β
βReally solid passive income calculator. Covers everything: DRIP compounding, Roth IRA tax savings, DCA contributions. The year-by-year breakdown is what I was missing from other tools.β
βAs someone planning retirement in 5 years, this dividend yield calculator showed me I need about 12% more in dividend stocks to hit my income target. Incredibly useful and completely free.β
βThe Congress trades tracker is genius. Saw that several senators were buying O (Realty Income) and immediately ran it through the DRIP calculator. Bought 50 shares the next day.β
Reviews reflect users' personal experiences. Not financial advice.
Leave a review βIf DividendFlow helped you see your future dividend income clearly, other investors deserve the same clarity. Your review takes 30 seconds and makes a real difference.
β±οΈ Takes 30 seconds Β· No signup Β· Free forever